Loading...

OTC Markets

Totals

Securities

12,252

Dollar Vol

$2.4B

Share Vol

3.9B

Trades

337,907

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
BIO
Financials

BIO
Bio-Rad Laboratories, Inc.

Class A Common Stock

288.16

-0.21

-0.07%

Delayed (15 Min) Trade Data: 12:00am 08/20/2025

Financials

Fiscal year ends 12/31

| Values in 000s USD

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Invalid date

12/30/2024

Invalid date

12/30/2023

Invalid date

12/30/2022

Invalid date

12/30/2021

2024-12-31 00:00:00

2023-12-31 00:00:00

2024-12-31 00:00:00

2022-12-31 00:00:00

2024-12-31 00:00:00

2021-12-31 00:00:00

2024-12-31 00:00:00

Revenues

Total Revenue

2,566,500

2,671,200

2,566,500

2,802,200

2,566,500

2,922,545

2,566,500

Cost of Revenue

1,187,600

1,244,300

1,187,600

1,234,900

1,187,600

1,284,449

1,187,600

Gross Profit

1,378,900

1,426,900

1,378,900

1,567,300

1,378,900

1,638,096

1,378,900

Operating Expenses

Research and Development

295,900

247,400

295,900

256,900

295,900

260,638

295,900

Sales, General and Admin

814,000

841,700

814,000

827,800

814,000

877,122

814,000

Non-Recurring Items

Other

Total Expenses

1,109,900

1,089,100

1,109,900

1,084,700

1,109,900

1,137,760

1,109,900

Operating Income

269,000

337,800

269,000

482,600

269,000

500,336

269,000

Income from Continuing Operations

Additional Income / Expense Items

(2,562,600)

(1,138,500)

(2,562,600)

(5,148,700)

(2,562,600)

4,950,270

(2,562,600)

Earnings Before Interest and Taxes

269,000

337,800

269,000

482,600

269,000

500,336

269,000

Interest Expense

(48,900)

(49,400)

(48,900)

(38,100)

(48,900)

(1,551)

(48,900)

Earnings Before Tax

(2,342,500)

(850,100)

(2,342,500)

(4,704,200)

(2,342,500)

5,449,055

(2,342,500)

Income Tax

(498,300)

(212,800)

(498,300)

(1,076,700)

(498,300)

1,194,798

(498,300)

Minority Interest

Equity Earnings

Net Income Cont. Operations

(1,844,200)

(637,300)

(1,844,200)

(3,627,500)

(1,844,200)

4,254,257

(1,844,200)

Non-Recurring Events

Discontinued Operations

Extraordinary Operations

Effect of Accounting Changes

Net Income

(1,844,200)

(637,300)

(1,844,200)

(3,627,500)

(1,844,200)

4,254,257

(1,844,200)

Key Financial Ratios

Earnings Per Share

-65.36

-21.82

-65.36

-121.79

-65.36

142.61

-65.36

Price/Earnings

-5.0262

Gross Margin

0.5373

0.5342

0.5373

0.5593

0.5373

0.5605

0.5373

Operating Margin

0.1048

0.1265

0.1048

0.1722

0.1048

0.1712

0.1048

Financial data presented is provided by Edgar Online and may differ from information contained in the issuer's annual and periodic reports, which are available under the "Disclosure" tab.

Neither the issuer nor OTC Markets Group is liable for any errors, omissions or other defects in the data presented below, or for any decisions taken in reliance of the data.

For information not originally reported in U.S. Dollars, conversion is based on applicable exchange rate on the last day of the period reported.

© 2025 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Market Groups Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.

NYSE

Securities

Other Bio-Rad Laboratories, Inc. Securities